The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel
Open accessAbstract
: There is abundant evidence that the risk of atherosclerotic vascular disease is directly related to plasma cholesterol levels. Accordingly, all of the national and transnational screening and therapeutic guidelines are based on total or LDL cholesterol. This presumes that cholesterol is the most important lipoprotein‐related proatherogenic risk variable. On the contrary, risk appears to be more directly related to the number of circulating atherogenic particles that contact and enter the arterial wall than to the measured concentration of cholesterol in these lipoprotein fractions. Each of the atherogenic lipoprotein particles contains a single molecule of apolipoprotein (apo) B and therefore the concentration of apo B provides a direct measure of the number of circulating atherogenic lipoproteins. Evidence from fundamental, epidemiological and clinical trial studies indicates that apo B is superior to any of the cholesterol indices to recognize those at increased risk of vascular disease and to judge the adequacy of lipid‐lowering therapy. On the basis of this evidence, we believe that apo B should be included in all guidelines as an indicator of cardiovascular risk. In addition, the present target adopted by the Canadian guideline groups of an apo B <90 mg dL−1 in high‐risk patients should be reassessed in the light of the new clinical trial results and a new ultra‐low target of <80 mg dL−1 be considered. The evidence also indicates that the apo B/apo A‐I ratio is superior to any of the conventional cholesterol ratios in patients without symptomatic vascular disease or diabetes to evaluate the lipoprotein‐related risk of vascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938
De Backer, G. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00347-6 · Cited by 2,251
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159
Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease: The Framingham Study
KANNEL, W. B., CASTELLI, W. P., GORDON, T., & MCNAMARA, P. M. (1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,057
Law, M. R., Wald, N. J., & Rudnicka, A. R. (2003) · BMJ · doi:10.1136/bmj.326.7404.1423 · Cited by 1,720
Walldius, G., Jungner, I., Holme, I., Aastveit, A. H., Kolar, W., & Steiner, E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07098-2 · Cited by 1,229
Self-citationStampfer, M. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110036029 · Cited by 1,079
Lamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Despre´s, J.-P. (1997) · Circulation · doi:10.1161/01.cir.95.1.69 · Cited by 1,077
Sharrett, A. R., Ballantyne, C. M., Coady, S. A., Heiss, G., Sorlie, P. D., Catellier, D., & Patsch, W. (2001) · Circulation · doi:10.1161/hc3501.095214 · Cited by 944
Self-citationMetabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896
Self-citationGardner, C. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110029028 · Cited by 843
Ridker, P. M., Rifai, N., Cook, N. R., Bradwin, G., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.3.326 · Cited by 744
de Graaf, J., Hak-Lemmers, H. L., Hectors, M. P., Demacker, P. N., Hendriks, J. C., & Stalenhoef, A. F. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.298 · Cited by 714
Self-citationPedersen, T. R., Olsson, A. G., Færgeman, O., Kjekshus, J., Wedel, H., Berg, K., Wilhelmsen, L., Haghfelt, T., Thorgeirsson, G., Pyörälä, K., et al. (1998) · Circulation · doi:10.1161/01.cir.97.15.1453 · Cited by 621
Garvey, W. T., Kwon, S., Zheng, D., Shaughnessy, S., Wallace, P., Hutto, A., Pugh, K., Jenkins, A. J., Klein, R. L., & Liao, Y. (2003) · Diabetes · doi:10.2337/diabetes.52.2.453 · Cited by 607
Gotto, A. M., Whitney, E., Stein, E. A., Shapiro, D. R., Clearfield, M., Weis, S., Jou, J. Y., Langendörfer, A., Beere, P. A., Watson, D. J., et al. (2000) · Circulation · doi:10.1161/01.cir.101.5.477 · Cited by 563
Self-citationWalldius, G., Jungner, I., Holme, I., Aastveit, A. H., Kolar, W., & Steiner, E. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00666-9 · Cited by 534
Self-citationPischon, T., Girman, C. J., Sacks, F. M., Rifai, N., Stampfer, M. J., & Rimm, E. B. (2005) · Circulation · doi:10.1161/circulationaha.104.532499 · Cited by 514
De Backer, G., Ambrosioni, E., Borch-Johnsen, K., Brotons, C., Cifkova, R., Dallongeville, J., Ebrahim, S., Faergeman, O., Graham, I., Mancia, G., et al. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.02.013 · Cited by 508
Self-citationLamarche, B., Moorjani, S., Lupien, P. J., Cantin, B., Bernard, P.-M., Dagenais, G. R., & Despre´s, J.-P. (1996) · Circulation · doi:10.1161/01.cir.94.3.273 · Cited by 476
Tribble, D. L., Holl, L. G., Wood, P. D., & Krauss, R. M. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90255-f · Cited by 467
Self-citationApolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment
Sniderman, A., Furberg, C., Keech, A., van Lennep, J. R., Frohlich, J., Jungner, I., & Walldius, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12663-3 · Cited by 457
Self-citationSt-Pierre, A. C., Cantin, B., Dagenais, G. R., Mauriège, P., Bernard, P.-M., Després, J.-P., & Lamarche, B. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000154144.73236.f4 · Cited by 422
Blake, G. J., Otvos, J. D., Rifai, N., & Ridker, P. M. (2002) · Circulation · doi:10.1161/01.cir.0000033222.75187.b9 · Cited by 409
Lipoprotein Heterogeneity and Apolipoprotein B Metabolism
Packard, C. J., & Shepherd, J. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.12.3542 · Cited by 402
Self-citationMarcovina, S. M., Albers, J. J., Henderson, L. O., & Hannon, W. H. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.5.773 · Cited by 342
Self-citationGenest, J. J., Frohlich, J. J., Fodor, G. J., & McPherson, R. (2003) · PubMed · Cited by 342
Self-citationSniderman, A. D., Scantlebury, T., & Cianflone, K. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00014 · Cited by 336
Self-citationGrundy, S. M. (2002) · Circulation · doi:10.1161/01.cir.0000038419.53000.d6 · Cited by 309
Durrington, P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14234-1 · Cited by 307
Self-citationMyocardial infarction in the familial forms of hypertriglyceridemia
Brunzell, J. D., Schrott, H. G., Motulsky, A. G., & Bierman, E. L. (1976) · Metabolism · doi:10.1016/0026-0495(76)90089-5 · Cited by 303
Rosenson, R. S., Otvos, J. D., & Freedman, D. S. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02427-x · Cited by 293
Self-citationWalldius, G., Jungner, I., Aastveit, A. H., Holme, I., Furberg, C. D., & Sniderman, A. D. (2004) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2004.254 · Cited by 290
Self-citationThrombogenic Factors and Recurrent Coronary Events
Moss, A. J., Goldstein, R. E., Marder, V. J., Sparks, C. E., Oakes, D., Greenberg, H., Weiss, H. J., Zareba, W., Brown, M. W., Liang, C.-S., et al. (1999) · Circulation · doi:10.1161/01.cir.99.19.2517 · Cited by 280
Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis.
SNIDERMAN, A. D., WOLFSON, C., TENG, B., FRANKLIN, F. A., BACHORIK, P. S., & KWITEROVICH, P. O. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-6-833 · Cited by 266
Self-citationPlasma very low density lipoproteins contain a single molecule of apolipoprotein B
Elovson, J., Chatterton, J. E., Bell, G. T., Schumaker, V. N., Reuben, M. A., Puppione, D. L., Reeve, J. R., & Young, N. L. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38425-x · Cited by 266
Zambon, A., Hokanson, J. E., Brown, B. G., & Brunzell, J. D. (1999) · Circulation · doi:10.1161/01.cir.99.15.1959 · Cited by 263
Simes, R. J., Marschner, I. C., Hunt, D., Colquhoun, D., Sullivan, D., Stewart, R. A. H., Hague, W., Keech, A., Thompson, P., White, H., et al. (2002) · Circulation · doi:10.1161/hc1002.105136 · Cited by 254
Self-citationPrevalence of risk factors in men with premature coronary artery disease
Genest, J. J., McNamara, J. R., Salem, D. N., & Schaefer, E. J. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90924-a · Cited by 243
Lipid disorders and mutations in the APOB gene
Whitfield, A. J., Barrett, P. H. R., van Bockxmeer, F. M., & Burnett, J. R. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.038026 · Cited by 243
Marcovina, S. M., Albers, J. J., Kennedy, H., Mei, J. V., Henderson, L. O., & Hannon, W. H. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.4.586 · Cited by 243
Self-citationTeng, B., Thompson, G. R., Sniderman, A. D., Forte, T. M., Krauss, R. M., & Kwiterovich, P. O. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.21.6662 · Cited by 242
Self-citationApolipoprotein B metabolism and the distribution of VLDL and LDL subfractions
Packard, C. J., Demant, T., Stewart, J. P., Bedford, D., Caslake, M. J., Schwertfeger, G., Bedynek, A., Shepherd, J., & Seidel, D. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32065-4 · Cited by 239
Self-citationJiang, R., Schulze, M. B., Li, T., Rifai, N., Stampfer, M. J., Rimm, E. B., & Hu, F. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1991 · Cited by 238
Distribution of lipids in 8,500 men with coronary artery disease
Rubins, H. B., Robins, S. J., Collins, D., Iranmanesh, A., Wilt, T. J., Mann, D., Mayo-Smith, M., Faas, F. H., Elam, M. B., Rutan, G. H., et al. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80761-9 · Cited by 238
Anber, V., Griffin, B. A., McConnell, M., Packard, C. J., & Shepherd, J. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05842-x · Cited by 238
Self-citationDejager, S., Bruckert, E., & Chapman, M. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40756-4 · Cited by 237
Self-citationGuerin, M., Lassel, T. S., Le Goff, W., Farnier, M., & Chapman, M. J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.1.189 · Cited by 237
Self-citationShai, I., Rimm, E. B., Hankinson, S. E., Curhan, G., Manson, J. E., Rifai, N., Stampfer, M. J., & Ma, J. (2004) · Circulation · doi:10.1161/01.cir.0000146339.57154.9b · Cited by 236
Talmud, P. J., Hawe, E., Miller, G. J., & Humphries, S. E. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000035521.22199.c7 · Cited by 233
Self-citationGriffin, B. A., Caslake, M. J., Yip, B., Tait, G. W., Packard, C. J., & Shepherd, J. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90131-2 · Cited by 231
Self-citationBjörnheden, T., Babyi, A., Bondjers, G., & Wiklund, O. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05770-6 · Cited by 230
Marcovina, S. M., Albers, J. J., Dati, F., Ledue, T. B., & Ritchie, R. F. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.10.1676 · Cited by 228
Self-citationSniderman, A. D., St-Pierre, A. C., Cantin, B., Dagenais, G. R., Després, J.-P., & Lamarche, B. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00262-5 · Cited by 224
Self-citationPrevalence of Risk Factors in Men With Premature Coronary Artery Disease
Genest, J. J., McNamara, J. R., Salem, D. N., & Schaefer, E. J. (1992) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-199203010-00011 · Cited by 217
Chapman, M. J., Laplaud, P. M., Luc, G., Forgez, P., Bruckert, E., Goulinet, S., & Lagrange, D. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38518-7 · Cited by 216
Self-citationGoff, D. C., D'Agostino, R. B., Haffner, S. M., & Otvos, J. D. (2005) · Metabolism · doi:10.1016/j.metabol.2004.09.002 · Cited by 205
Self-citationCastro Cabezas, M., de Bruin, T. W., de Valk, H. W., Shoulders, C. C., Jansen, H., & Willem Erkelens, D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116544 · Cited by 200
Low-density lipoprotein particle number and risk for cardiovascular disease
Cromwell, W. C., & Otvos, J. D. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0050-5 · Cited by 198
Frost, P. H., & Havel, R. J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00034-4 · Cited by 193
Cannon, C. P. (2004) · Cited by 189
FODOR, J. G., Frohlich, J., Genest, J. J., & McPherson, P. R. (2000) · Europe PMC (PubMed Central) · Cited by 185
Self-citationAtherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
Chapman, M. J., Guérin, M., & Bruckert, É. (1998) · PubMed · Cited by 178
Self-citationLamarche, B., Despre´s, J.-P., Moorjani, S., Cantin, B., Dagenais, G. R., & Lupien, P.-J. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80760-7 · Cited by 170
Miller, B. D., Alderman, E. L., Haskell, W. L., Fair, J. M., & Krauss, R. M. (1996) · Circulation · doi:10.1161/01.cir.94.9.2146 · Cited by 162
Self-citationHurt-Camejo, E., Camejo, G., Rosengren, B., Lopez, F., Wiklund, O., & Bondjers, G. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42610-0 · Cited by 162
Apolipoprotein Concentrations During Treatment and Recurrent Coronary Artery Disease Events
van Lennep, J. E. R., Westerveld, H. T., van Lennep, H. W. O. R., Zwinderman, A. H., Erkelens, D. W., & van der Wall, E. E. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.11.2408 · Cited by 160
Lipoprotein Size and Atherosclerosis Susceptibility in Apoe −/− and Ldlr −/− Mice
Véniant, M. M., Withycombe, S. K., & Young, S. G. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1001.097780 · Cited by 157
Watts, G. F., Mandalia, S., Brunt, J. N. H., Slavin, B. M., COLTART, D. J., & Lewis, B. (1993) · Metabolism · doi:10.1016/0026-0495(93)90199-x · Cited by 146
Lamarche, B., St-Pierre, A., Ruel, I. L., Cantin, B., Dagenais, G. R., & Després, J.-P. (2001) · PubMed · Cited by 142
Sattar, N. A., Williams, K., Sniderman, A. D., D’Agostino, R., & Haffner, S. M. (2004) · Circulation · doi:10.1161/01.cir.0000145660.60487.94 · Cited by 140
Self-citationVeerkamp, M. J., Graaf, J. D., Hendriks, J. C. M., Demacker, P. N. M., & Stalenhoef, A. F. H. (2004) · Circulation · doi:10.1161/01.cir.0000130646.93255.86 · Cited by 139
Self-citationRelationship between plasma lipid concentrations and coronary artery disease in 496 patients.
Gotto, A. M., Gorry, G. A., Thompson, J. R., Cole, J. S., Trost, R., Yeshurun, D., & DeBakey, M. E. (1977) · Circulation · doi:10.1161/01.cir.56.5.875 · Cited by 136
Low density lipoprotein size, pravastatin treatment, and coronary events.
Campos, H. (2001) · JAMA · doi:10.1001/jama.286.12.1468 · Cited by 132
Williams, K., Sniderman, A. D., Sattar, N. A., D’Agostino, R., Wagenknecht, L. E., & Haffner, S. M. (2003) · Circulation · doi:10.1161/01.cir.0000097113.11419.9e · Cited by 131
Self-citationAustin, M. A., Rodriguez, B. L., McKnight, B., McNeely, M. J., Edwards, K. L., Curb, J. D., & Sharp, D. S. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00956-5 · Cited by 129
Smallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men
Holl, L. G., Krauss, R. M., Williams, P. T., Superko, H. R., Haskell, W. L., Alderman, E. L., Patricia, J., & Blanche, P. J. (2015) · Cited by 122
Self-citationDurrington, P. N., Hunt, L. P., Ishola, M., Kane, J. W., & Stephens, W. P. (1986) · Heart · doi:10.1136/hrt.56.3.206 · Cited by 120
Self-citationNovel Metabolic Risk Factors for Heart Failure
Ingelsson, E., Ärnlöv, J., Sundström, J., Zethelius, B., Vessby, B. O., & Lind, L. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.059 · Cited by 116
LDL Size and Risk of Coronary Heart Disease in Elderly Men and Women
Mykkänen, L., Kuusisto, J., Haffner, S. M., Laakso, M., & Austin, M. A. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.11.2742 · Cited by 112
Self-citationBarbir, M., Wile, D. B., Trayner, I., Aber, V. R., & Thompson, G. R. (1988) · Heart · doi:10.1136/hrt.60.5.397 · Cited by 107
Metabolic abnormalities: triglyceride and low-density lipoprotein
Krauss, R. M., & Siri, P. W. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.016 · Cited by 102
Self-citationCampos, H., Roederer, G. O., Lussier‐Cacan, S., Davignon, J., & Krauss, R. M. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.8.1043 · Cited by 101
Self-citationWilliams, P. T., Krauss, R. M., VRANIZAN, K. M., Stefanick, M. L., Wood, P. D., & Lindgren, F. T. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.3.332 · Cited by 97
Self-citationNordestgaard, B. G., & Zilversmit, D. B. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.2.176 · Cited by 85
Sniderman, A. D., Cabezas, M. C., Ribalta, J., Carmena, R., de Bruin, T. W., Graaf, J. D., Erkelens, D. W., Humphries, S. E., Masana, L., Real, J. T., et al. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00941.x · Cited by 82
Self-citationEffect of moderate hypertriglyceridemia on the relation of plasma total and LDL apo B levels
Sniderman, A. D., Vu, H., & Cianflone, K. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90050-d · Cited by 81
Self-citationKukita, H., Hamada, M., Hiwada, K., & Kokubu, T. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90093-0 · Cited by 64
Low Density Lipoprotein Particle Size and Risk of Early-Onset Myocardial Infarction in Women
Kamigaki, A., Siscovick, D. S., Schwartz, S. M., Psaty, B. M., Edwards, K. L., Raghunathan, T. E., & Austin, M. A. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.10.939 · Cited by 59
Keulen, E. T. P., Kruijshoop, M., Schaper, N. C., Hoeks, A. P. G., & de Bruin, T. W. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0202.104100 · Cited by 59
Stein, E. A., Sniderman, A. D., & Laskarzewski, P. M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.08.006 · Cited by 58
Self-citationWägner, A. M., Pérez, A., Zapico, E., & Ordóñez‐Llanos, J. (2003) · Diabetes Care · doi:10.2337/diacare.26.7.2048 · Cited by 58
Durrington, P. N., Bolton, C., & Hartog, M. (1978) · Clinica Chimica Acta · doi:10.1016/0009-8981(78)90038-4 · Cited by 56
Self-citationFesta, A., Agostino, R. B. D., Mykkänen, L., Tracy, R. P., Howard, B. V., & Haffner, S. M. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.3.605 · Cited by 53
Self-citationMeijssen, S., Cabezas, M. C., Twickler, T. B., Jansen, H., & Erkelens, D. W. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32015-0 · Cited by 53
Self-citationBruno, G., Merletti, F., Biggeri, A., Bargero, G., Cerai, S. P., Pagano, G., & Cavallo‐Perin, P. (2006) · Diabetologia · doi:10.1007/s00125-006-0195-6 · Cited by 48
Simon, A. C., Chironi, G. N., Gariépy, J., Pino, M. D., & Levenson, J. A. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.10.017 · Cited by 47
Corsetti, J. P., Zaręba, W., Moss, A. J., & Sparks, C. E. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.07.019 · Cited by 43
Griffin, B. A., Minihane, A. M., Furlonger, N., Chapman, C. M. L., Murphy, M. C., WILLIAMS, D., Wright, J. R., & Williams, C. M. (1999) · Clinical Science · doi:10.1042/cs0970269 · Cited by 36
Governance of the concentration of plasma LDL: a reevaluation of the LDL receptor paradigm
Sniderman, A. D., Zhang, X., & Cianflone, K. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00282-8 · Cited by 33
Self-citationVäisänen, S., Baumstark, M. W., Penttilä, I., Bouchard, C., Halonen, P. M., Rankinen, T., Berg, A., & Rauramaa, R. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1665440 · Cited by 23
Collins-Nakai, R. L., & Dagenais, G. R. (1999) · PubMed · Cited by 18
Cited by
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Self-citationClinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Jellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094
Feinman, R. D., Pogozelski, W. K., Astrup, A., Bernstein, R. K., Fine, E. J., Westman, E. C., Accurso, A., Frassetto, L., Gower, B. A., McFarlane, S. I., et al. (2015) · Nutrition · doi:10.1016/j.nut.2014.06.011 · Cited by 912
“These include apolipoprotein (apo) B [71], ratio of total cholesterol to HDL, higher populations of the smaller dense LDL known as pattern B [72,73], as well as the ratio of apoB to apoA1.”
Metadata
- Authors
- BARTER, P. J., BALLANTYNE, C. M., CARMENA, R., CABEZAS, M. C., CHAPMAN, M. J., COUTURE, P., DE GRAAF, J., DURRINGTON, P. N., FAERGEMAN, O., FROHLICH, J., FURBERG, C. D., GAGNE, C., HAFFNER, S. M., HUMPHRIES, S. E., JUNGNER, I., KRAUSS, R. M., KWITEROVICH, P., MARCOVINA, S., PACKARD, C. J., PEARSON, T. A., REDDY, K. S., ROSENSON, R., SARRAFZADEGAN, N., SNIDERMAN, A. D., STALENHOEF, A. F., STEIN, E., TALMUD, P. J., TONKIN, A. M., WALLDIUS, G., & WILLIAMS, K. M. S.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2006-02-10
- Volume
- 259
- Issue
- 3
- Pages
- 247-258
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W2045054080
- Cited by
- 464
- References
- 105
- FWCI
- 44.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.